Hepatitis B Virus Immunization and Neonatal Acquisition of Persistent Infection in England and Wales
Background: It is believed that between 2% and 5% of infants born to hepatitis B virus (HBV)-infected mothers at a high risk of perinatal transmission will become persistently infected despite immunization starting at birth. We investigated factors associated with breakthrough infections.
Methods: Sixty-nine samples from HBV-infected infants born between 2003 and 2015 were tested for HBV serological and molecular markers. Sequencing and epitope phenotyping were used to investigate alterations in hepatitis B surface antigen (HBsAg) sequence and antigenicity in infants and in mothers known to have transmitted and not to have transmitted virus to their infants.
Results: Vaccine/hepatitis B immune globulin uptake was complete in the majority of HBV-infected infants. A minority (8 [12%]) had detectable plasma antibody to HBsAg at 12 months. Twenty-five of 68 (37%) infants harbored a virus with amino acid changes in the HBsAg "a" determinant, of which 13 displayed altered HBsAg antigenicity. Viral load was 30-fold higher in maternal samples from those who transmitted.
Conclusions: Our data provide evidence to suggest that immune selection drives change at mother-infant transmission, resulting in the alteration of HBsAg antigenicity. These changes may play a role in immunization failure, but other factors including viral load may be more important. Continued monitoring of vaccine efficacy is essential.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:218 |
---|---|
Enthalten in: |
The Journal of infectious diseases - 218(2018), 5 vom: 24. Juli, Seite 726-733 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
May, Shoshanna [VerfasserIn] |
---|
Links: |
---|
Themen: |
Epitopes |
---|
Anmerkungen: |
Date Completed 10.09.2019 Date Revised 10.09.2019 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/infdis/jiy209 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM283362359 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM283362359 | ||
003 | DE-627 | ||
005 | 20231225040622.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/infdis/jiy209 |2 doi | |
028 | 5 | 2 | |a pubmed24n0944.xml |
035 | |a (DE-627)NLM283362359 | ||
035 | |a (NLM)29688415 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a May, Shoshanna |e verfasserin |4 aut | |
245 | 1 | 0 | |a Hepatitis B Virus Immunization and Neonatal Acquisition of Persistent Infection in England and Wales |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.09.2019 | ||
500 | |a Date Revised 10.09.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Background: It is believed that between 2% and 5% of infants born to hepatitis B virus (HBV)-infected mothers at a high risk of perinatal transmission will become persistently infected despite immunization starting at birth. We investigated factors associated with breakthrough infections | ||
520 | |a Methods: Sixty-nine samples from HBV-infected infants born between 2003 and 2015 were tested for HBV serological and molecular markers. Sequencing and epitope phenotyping were used to investigate alterations in hepatitis B surface antigen (HBsAg) sequence and antigenicity in infants and in mothers known to have transmitted and not to have transmitted virus to their infants | ||
520 | |a Results: Vaccine/hepatitis B immune globulin uptake was complete in the majority of HBV-infected infants. A minority (8 [12%]) had detectable plasma antibody to HBsAg at 12 months. Twenty-five of 68 (37%) infants harbored a virus with amino acid changes in the HBsAg "a" determinant, of which 13 displayed altered HBsAg antigenicity. Viral load was 30-fold higher in maternal samples from those who transmitted | ||
520 | |a Conclusions: Our data provide evidence to suggest that immune selection drives change at mother-infant transmission, resulting in the alteration of HBsAg antigenicity. These changes may play a role in immunization failure, but other factors including viral load may be more important. Continued monitoring of vaccine efficacy is essential | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Epitopes |2 NLM | |
650 | 7 | |a Hepatitis B Surface Antigens |2 NLM | |
650 | 7 | |a Hepatitis B Vaccines |2 NLM | |
700 | 1 | |a Mandal, Sema |e verfasserin |4 aut | |
700 | 1 | |a Keel, Philip |e verfasserin |4 aut | |
700 | 1 | |a Haywood, Becky |e verfasserin |4 aut | |
700 | 1 | |a Ngui, Siew Lin |e verfasserin |4 aut | |
700 | 1 | |a Ramsay, Mary |e verfasserin |4 aut | |
700 | 1 | |a Tedder, Richard S |e verfasserin |4 aut | |
700 | 1 | |a Ijaz, Samreen |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infectious diseases |d 1945 |g 218(2018), 5 vom: 24. Juli, Seite 726-733 |w (DE-627)NLM000005819 |x 1537-6613 |7 nnns |
773 | 1 | 8 | |g volume:218 |g year:2018 |g number:5 |g day:24 |g month:07 |g pages:726-733 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/infdis/jiy209 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 218 |j 2018 |e 5 |b 24 |c 07 |h 726-733 |